258 related articles for article (PubMed ID: 7835220)
1. Oxidation of R(+)- and S(-)-carvedilol by rat liver microsomes. Evidence for stereoselective oxidation and characterization of the cytochrome P450 isozymes involved.
Fujimaki M
Drug Metab Dispos; 1994; 22(5):700-8. PubMed ID: 7835220
[TBL] [Abstract][Full Text] [Related]
2. Stereoselective metabolism of carvedilol in the rat. Use of enantiomerically radiolabeled pseudoracemates.
Fujimaki M; Shintani S; Hakusui H
Drug Metab Dispos; 1991; 19(4):749-53. PubMed ID: 1680650
[TBL] [Abstract][Full Text] [Related]
3. Stereoselective metabolism of cibenzoline, an antiarrhythmic drug, by human and rat liver microsomes: possible involvement of CYP2D and CYP3A.
Niwa T; Shiraga T; Mitani Y; Terakawa M; Tokuma Y; Kagayama A
Drug Metab Dispos; 2000 Sep; 28(9):1128-34. PubMed ID: 10950860
[TBL] [Abstract][Full Text] [Related]
4. Stereoselective N-demethylation of chlorpheniramine by rat-liver microsomes and the involvement of cytochrome P450 isozymes.
Nomura A; Sakurai E; Hikichi N
J Pharm Pharmacol; 1997 Mar; 49(3):257-62. PubMed ID: 9231341
[TBL] [Abstract][Full Text] [Related]
5. Cytochrome P4502D isozymes catalyze the 4-hydroxylation of methamphetamine enantiomers.
Lin LY; Kumagai Y; Hiratsuka A; Narimatsu S; Suzuki T; Funae Y; Distefano EW; Cho AK
Drug Metab Dispos; 1995 Jun; 23(6):610-4. PubMed ID: 7587941
[TBL] [Abstract][Full Text] [Related]
6. Participation of cytochrome P450-2B and -2D isozymes in the demethylenation of methylenedioxymethamphetamine enantiomers by rats.
Kumagai Y; Lin LY; Hiratsuka A; Narimatsu S; Suzuki T; Yamada H; Oguri K; Yoshimura H; Cho AK
Mol Pharmacol; 1994 Feb; 45(2):359-65. PubMed ID: 7906857
[TBL] [Abstract][Full Text] [Related]
7. Purification and characterization of a cytochrome P-450 isozyme catalyzing bunitrolol 4-hydroxylation in liver microsomes of male rats.
Suzuki T; Narimatsu S; Fujita S; Masubuchi Y; Umeda S; Imaoka S; Funae Y
Drug Metab Dispos; 1992; 20(3):367-73. PubMed ID: 1355709
[TBL] [Abstract][Full Text] [Related]
8. Stereoselective glucuronidation of carvedilol in human liver and intestinal microsomes.
Hanioka N; Tanaka S; Moriguchi Y; Narimatsu S
Pharmacology; 2012; 90(3-4):117-24. PubMed ID: 22814440
[TBL] [Abstract][Full Text] [Related]
9. In-vitro metabolic interaction of bunitrolol enantiomers in rabbit liver microsomes.
Narimatsu S; Mizukami T; Huang Y; Masubuchi Y; Suzuki T
J Pharm Pharmacol; 1996 Nov; 48(11):1185-9. PubMed ID: 8961170
[TBL] [Abstract][Full Text] [Related]
10. Identification of cytochrome P-450 isozymes involved in the hydroxylation of dantrolene by rat liver microsomes.
Jayyosi Z; Villoutreix J; Ziegler JM; Batt AM; De Maack F; Siest G; Thomas PE
Drug Metab Dispos; 1993; 21(5):939-45. PubMed ID: 7902259
[TBL] [Abstract][Full Text] [Related]
11. Metabolism of the antimammary cancer antiestrogenic agent tamoxifen. I. Cytochrome P-450-catalyzed N-demethylation and 4-hydroxylation.
Mani C; Gelboin HV; Park SS; Pearce R; Parkinson A; Kupfer D
Drug Metab Dispos; 1993; 21(4):645-56. PubMed ID: 8104124
[TBL] [Abstract][Full Text] [Related]
12. Application of substrate depletion assay to evaluation of CYP isoforms responsible for stereoselective metabolism of carvedilol.
Iwaki M; Niwa T; Bandoh S; Itoh M; Hirose H; Kawase A; Komura H
Drug Metab Pharmacokinet; 2016 Dec; 31(6):425-432. PubMed ID: 27836712
[TBL] [Abstract][Full Text] [Related]
13. The molecular mechanisms of two common polymorphisms of drug oxidation--evidence for functional changes in cytochrome P-450 isozymes catalysing bufuralol and mephenytoin oxidation.
Meyer UA; Gut J; Kronbach T; Skoda C; Meier UT; Catin T; Dayer P
Xenobiotica; 1986 May; 16(5):449-64. PubMed ID: 2874666
[TBL] [Abstract][Full Text] [Related]
14. An evaluation of cytochrome P450 isoform activities in the female dark agouti (DA) rat: relevance to its use as a model of the CYP2D6 poor metaboliser phenotype.
Barham HM; Lennard MS; Tucker GT
Biochem Pharmacol; 1994 Apr; 47(8):1295-307. PubMed ID: 8185638
[TBL] [Abstract][Full Text] [Related]
15. Use of quinidine inhibition to define the role of the sparteine/debrisoquine cytochrome P450 in metoprolol oxidation by human liver microsomes.
Otton SV; Crewe HK; Lennard MS; Tucker GT; Woods HF
J Pharmacol Exp Ther; 1988 Oct; 247(1):242-7. PubMed ID: 3171974
[TBL] [Abstract][Full Text] [Related]
16. Development of a high-performance liquid chromatographic method for the analysis of enatiomer/enantiomer interaction in oxidative metabolism of bunitrolol in rat liver microsomes.
Narimatsu S; Huang Y; Mizukami T; Masubuchi Y; Suzuki T
Anal Biochem; 1994 Oct; 222(1):256-61. PubMed ID: 7856858
[TBL] [Abstract][Full Text] [Related]
17. Bufuralol hydroxylation by cytochrome P450 2D6 and 1A2 enzymes in human liver microsomes.
Yamazaki H; Guo Z; Persmark M; Mimura M; Inoue K; Guengerich FP; Shimada T
Mol Pharmacol; 1994 Sep; 46(3):568-77. PubMed ID: 7935340
[TBL] [Abstract][Full Text] [Related]
18. Biotransformation of 6-methoxy-3-(3',4',5'-trimethoxy-benzoyl)-1H-indole (BPR0L075), a novel antimicrotubule agent, by mouse, rat, dog, and human liver microsomes.
Yao HT; Wu YS; Chang YW; Hsieh HP; Chen WC; Lan SJ; Chen CT; Chao YS; Chang L; Sun HY; Yeh TK
Drug Metab Dispos; 2007 Jul; 35(7):1042-9. PubMed ID: 17403915
[TBL] [Abstract][Full Text] [Related]
19. Oxidation of 1,8-cineole, the monoterpene cyclic ether originated from eucalyptus polybractea, by cytochrome P450 3A enzymes in rat and human liver microsomes.
Miyazawa M; Shindo M; Shimada T
Drug Metab Dispos; 2001 Feb; 29(2):200-5. PubMed ID: 11159812
[TBL] [Abstract][Full Text] [Related]
20. Species differences in stereoselective metabolism of mephenytoin by cytochrome P450 (CYP2C and CYP3A).
Yasumori T; Chen L; Nagata K; Yamazoe Y; Kato R
J Pharmacol Exp Ther; 1993 Jan; 264(1):89-94. PubMed ID: 8423554
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
